Leiden university medical center (LUMC) — Leiden, South Holland

Public research footprint of Leiden university medical center (LUMC), compiled from the ClinicalTrials.gov public registry.

652

Registered studies

182

Active

106

Recruiting now

279

Completed

Stopped or withdrawn

Most-studied conditions

Female Urogenital Diseases and Pregnancy Complications · Lung Cancer - Non Small Cell Squamous · Myasthenia Gravis · Decompensated Liver Cirrhosis

Recently updated registry entries

NCT03945773 — Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or… (Completed)
NCT05265273 — A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized… (Recruiting)
NCT05912517 — A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Leiden university medical center (LUMC)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.